Haiteng Deng Selected Research

2,4- bis(N,N'- di(carboxymethyl)aminomethyl)fluorescein

3/2019	Development of a dual-functional conjugate of antigenic peptide and Fc-III mimetics (DCAF) for targeted antibody blocking.
1/2019	Targeted Antibody Blocking by a Dual-Functional Conjugate of Antigenic Peptide and Fc-III Mimetics (DCAF).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Haiteng Deng Research Topics

Disease

33	Neoplasms (Cancer) 03/2022 - 08/2008
6	Infections 03/2019 - 04/2013
6	Ovarian Neoplasms (Ovarian Cancer) 01/2019 - 06/2013
5	Multiple Myeloma 01/2020 - 06/2013
4	Carcinogenesis 10/2021 - 05/2014
4	Starvation 01/2021 - 04/2012
4	Inflammation (Inflammations) 01/2021 - 08/2008
4	Breast Neoplasms (Breast Cancer) 10/2020 - 06/2013
3	Obesity 01/2022 - 08/2015
3	Renal Cell Carcinoma (Grawitz Tumor) 08/2020 - 01/2018
3	Necrosis 01/2018 - 01/2013
2	Melanoma (Melanoma, Malignant) 10/2022 - 01/2020
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 09/2021 - 01/2018
2	Rheumatoid Arthritis 09/2021 - 10/2014
2	Lung Neoplasms (Lung Cancer) 01/2021 - 10/2018
2	Adenocarcinoma of Lung 01/2021 - 01/2018
2	Carcinoma (Carcinomatosis) 08/2020 - 01/2019
2	Myasthenia Gravis 03/2019 - 01/2019
2	Insulin Resistance 01/2019 - 08/2015
2	Prostatic Neoplasms (Prostate Cancer) 10/2018 - 01/2008
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2018 - 11/2017
2	Hypoxia (Hypoxemia) 01/2018 - 10/2012
2	Pre-Eclampsia (Preeclampsia) 09/2016 - 05/2014
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2015 - 01/2015
2	Tuberculosis (Tuberculoses) 07/2014 - 10/2009
1	Neoplasm Metastasis (Metastasis) 10/2022
1	COVID-19 10/2022
1	Rectal Neoplasms (Rectal Cancer) 01/2022
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 10/2021
1	Ankylosing Spondylitis 09/2021
1	Rheumatic Diseases (Rheumatism) 09/2021
1	Osteoarthritis 09/2021
1	Colorectal Neoplasms (Colorectal Cancer) 08/2021
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2021
1	Plague (Bubonic Plague) 01/2021
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021
1	Genomic Instability 01/2021
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2021
1	Chromosomal Instability (Chromosome Stability) 01/2021
1	Endometriosis 01/2021

Drug/Important Bio-Agent (IBA)

21	Proteins (Proteins, Gene)FDA Link 10/2021 - 02/2013
8	Biomarkers (Surrogate Marker)IBA 03/2022 - 05/2014
5	EnzymesIBA 10/2022 - 11/2014
5	AntibodiesIBA 10/2022 - 10/2018
5	NAD (NADH)IBA 01/2021 - 08/2006
5	Pharmaceutical PreparationsIBA 01/2019 - 01/2013
4	Glucose (Dextrose)FDA LinkGeneric 10/2022 - 10/2017
4	Lysine (L-Lysine)FDA Link 10/2022 - 01/2018
4	Phosphotransferases (Kinase)IBA 01/2022 - 01/2012
4	Cisplatin (Platino)FDA LinkGeneric 12/2017 - 11/2014
4	LigandsIBA 06/2016 - 08/2008
3	Nicotinamide MononucleotideIBA 01/2021 - 11/2020
3	UbiquitinIBA 01/2021 - 02/2013
3	LipidsIBA 01/2018 - 09/2014
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2016 - 01/2015
2	Biological ProductsIBA 01/2022 - 01/2021
2	AntioxidantsIBA 01/2022 - 11/2014
2	ImmunosorbentsIBA 09/2021 - 01/2018
2	AutoantibodiesIBA 09/2021 - 01/2018
2	Chaperonin 60IBA 08/2021 - 01/2019
2	RNA (Ribonucleic Acid)IBA 01/2021 - 01/2019
2	Ligases (Synthetase)IBA 01/2021 - 05/2014
2	15-hydroxyprostaglandin dehydrogenaseIBA 01/2021 - 01/2018
2	coactivator-associated arginine methyltransferase 1IBA 10/2020 - 10/2019
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2020 - 07/2011
2	Immune Checkpoint InhibitorsIBA 01/2020 - 10/2018
2	2,4- bis(N,N'- di(carboxymethyl)aminomethyl)fluoresceinIBA 03/2019 - 01/2019
2	Cholinergic ReceptorsIBA 03/2019 - 01/2019
2	Antiviral Agents (Antivirals)IBA 01/2019 - 01/2018
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2018 - 10/2012
2	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 06/2013
2	VimentinIBA 07/2016 - 11/2014
2	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 02/2016 - 02/2013
2	Peptide Hydrolases (Proteases)FDA Link 01/2016 - 08/2015
2	NitrogenIBA 04/2015 - 10/2012
2	AcidsIBA 05/2013 - 10/2012
1	Melanins (Melanin)IBA 10/2022
1	Protons (Proton)IBA 10/2022
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 10/2022
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 10/2022
1	Neutralizing AntibodiesIBA 10/2022
1	Nicotinamide N-MethyltransferaseIBA 03/2022
1	N-nitroso-N-methyltyramine (NNMT)IBA 03/2022
1	Niacinamide (Nicotinamide)FDA LinkGeneric 01/2022
1	FlavonoidsIBA 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2021
1	AutoantigensIBA 09/2021
1	Peptidoglycan (Murein)IBA 09/2021
1	peptidoglycan recognition proteinIBA 09/2021
1	Antigen-Antibody Complex (Immune Complex)IBA 09/2021
1	Adenine FDA LinkGeneric 08/2021
1	Carbon Tetrachloride (Tetrachloromethane)IBA 01/2021
1	ProstaglandinsIBA 01/2021
1	Dinoprostone (PGE2)FDA Link 01/2021
1	Methionine (L-Methionine)FDA Link 01/2021
1	Thioacetamide (Thioacetamid)IBA 01/2021

Therapy/Procedure

6	Therapeutics 01/2022 - 11/2015
2	Immunotherapy 01/2020 - 11/2018
2	Drug Therapy (Chemotherapy) 12/2017 - 06/2013
1	Neoadjuvant Therapy 01/2022